136 Chapter 5 5 References 1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019:a systematic analysis for the global burden of disease study 2019. Lancet 2020;396:1204–22. 2. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the recognise asthma and link to symptoms and experience (realise) survey. NPJ Prim Care Respir Med 2014;24:1–10. 3. Haselkorn T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the expert panel report 3 guidelines, increases risk for future severe asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. J Allergy Clin Immunol 2009;124:895–902. 4. Schatz M, Zeiger RS, Yang S-J, et al. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest 2012;141:66–72. 5. Guilbert TW, Garris C, Jhingran P, et al. Asthma that is not well- controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma 2011;48:126– 32. 6. Global Initiative for Asthma. Global Straregy for asthma management and prevention, 2021. Available: https://ginasthma.org/wp-content/ uploads/2021/05/GINA-Main-Report2021-V2-WMS.pdf%0Ahttps:// ginasthma.org/gina-reports/ [Accessed 22 Mar 2022]. 7. Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting b2- agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J 2020;55. doi:10.1183/13993003.01872- 2019. [Epub ahead of print: 16 04 2020]. 8. Godard P, Chanez P, Siraudin L, et al. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002;19:61–7. 9. Dekhuijzen R, Lavorini F, Usmani OS, et al. Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here? J Allergy Clin Immunol Pract 2018;6:785–93. 10. Jentzsch NS, Camargos P, Sarinho ESC, et al. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012;106:338–43. 11. Lasmar L, Camargos P, Champs NS, et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 2009;64:784–9. 12. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105:930–8. 13. Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract 2017;5:1071–81. 14. Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011;128:1185–91. 15. Jansen EM, van de Hei SJ, Dierick BJH, et al. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J Thorac Dis 2021;13:3846-3864. 16. Dima AL, Hernandez G, Cunillera O, et al. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J 2015;45:994–1018.
RkJQdWJsaXNoZXIy MTk4NDMw